Trial Details
Not RecruitingBasic Information
| Clinical ID | c5064 |
|---|---|
| Identifier | EUCTR2019-004469-41-DE |
| Trial Title | A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Oral PN-943 in Subjects with Moderate to Severe Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Ulcerative colitis (US) is a chronic relapsing inflammatory bowel disease of the large intestine characterized by bloody diarrhoea, abdominal cramps and fatigue. UC is characterized by inflammation and ulceration of mainly the mucosal and occasionally sub |
| Interventions | Product Code: PN-943Pharmaceutical Form: TabletCurrent Sponsor code: PN-943Other descriptive name: PN-943Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 150-Pharmaceutical form of the place |
Participant Information
| Sponsor | Protagonist Therapeutics, Inc |
|---|---|
| City | NULL |
| Country/Region | Russia;Hungary;United States;Ukraine;Canada;Austria;South Korea;Poland;Italy;Georgia;Serbia;Bulgaria;Germany |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |